MDxHealth SA (MDXH) Tops Q2 EPS

MDxHealth SA (NASDAQ: MDXH) reported Q2 EPS of ($0.12), $0.45 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $6.41 million.

GUIDANCE:

MDxHealth SA sees Q3 2022 revenue of $40-42 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• BMO Capital on FedEx (FDX): 'Guidance Appears Consistent With Our Forecasts'
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance